Preparation of a mesoporous silica-based nano-vehicle for dual DOX/CPT pH-triggered delivery

References

• Agostini A, Mondragón L, Coll C, et al. (2012a). Dual enzyme-triggered controlled release on capped nanometric silica mesoporous supports. ChemistryOpen 1:17–20.
   PubMed Web of Science ®Google Scholar
• Agostini A, Mondragón L, Pascual L, et al. (2012b). Design of enzyme-mediated controlled release systems based on silica mesoporous supports capped with ester-glycol groups. Langmuir 28:14766–76.
   PubMed Web of Science ®Google Scholar
• Argyo C, Weiss V, Bräuchle C, Bein T. (2014). Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery. Chem Mater 26:435–51.
   Web of Science ®Google Scholar
• Aznar E, Sancenon F, Marcos MD, et al. (2012). Delivery modulation in silica mesoporous supports via alkyl chain pore outlet decoration. Langmuir 28:2986–96.
   PubMed Web of Science ®Google Scholar
• Brinkhuis RP, de Graaf F, Hansen MB, et al. (2013). Dynamically functionalized polymersomes viahydrazone exchange. Polym Chem 4:1345–50.
   Web of Science ®Google Scholar
• Camacho KM, Kumar S, Menegatti S, et al. (2015). Synergistic antitumor activity of camptothecin–doxorubicin combinations and their conjugates with hyaluronic acid. J Control Release 210:198–207.
   PubMed Web of Science ®Google Scholar
• Cao Y, Wang B, Wang Y, Lou D. (2014). Polymer-controlled core–shell nanoparticles: a novel strategy for sequential drug release. RSC Adv 4:30430.
   Web of Science ®Google Scholar
• Cheng S-H, Lee C-H, Yang C-S, et al. (2009). Mesoporous silica nanoparticles functionalized with an oxygen-sensing probe for cell photodynamic therapy: potential cancer theranostics. J Mater Chem 19:1252.
   Web of Science ®Google Scholar
• Choi KY, Liu G, Lee S, Chen X. (2012). Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale 4:330–42.
   PubMed Web of Science ®Google Scholar
• Coti KK, Belowich ME, Liong M, et al. (2009). Mechanised nanoparticles for drug delivery. Nanoscale 1:16–39.
   PubMed Web of Science ®Google Scholar
• de Juan F, Ruiz-Hitzky E. (2000). Selective functionalization of mesoporous silica. Adv Mater 12:430–2.
   Web of Science ®Google Scholar
• El Sayed S, Gimenez C, Aznar E, et al. (2015). Highly selective and sensitive detection of glutathione using mesoporous silica nanoparticles capped with disulfide-containing oligo(ethylene glycol) chains. Org Biomol Chem 13:1017–21.
   PubMed Web of Science ®Google Scholar
• Fan J, Fang G, Wang X, et al. (2011). Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Nanotechnology 22:455102.
   PubMed Web of Science ®Google Scholar
• Fisichella M, Dabboue H, Bhattacharyya S, et al. (2009). Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes. Toxicol. in Vitro 23:697–703.
   PubMed Web of Science ®Google Scholar
• Gao W, Chan JM, Farokhzad OC. (2010). pH-responsive nanoparticles for drug delivery. Mol Pharmaceutics 7:1913–20.
   PubMed Web of Science ®Google Scholar
• Huan M, Zhang B, Teng Z, et al. (2012). In vitro and in vivo antitumor activity of a novel pH-activated polymeric drug delivery system for doxorubicin. PLoS One 7:e44116.
   PubMed Web of Science ®Google Scholar
• Huang CK, Lo CL, Chen HH, Hsiue GH. (2007). Multifunctional micelles for cancer cell targeting, distribution imaging, and anticancer drug delivery. Adv Funct Mater 17:2291–7.
   Web of Science ®Google Scholar
• Huang Y, Xu S, Lin VSY. (2011). Bifunctionalized mesoporous materials with site-separated brønsted acids and bases: catalyst for a two-step reaction sequence. Angew Chem Int Ed 50:661–4.
   PubMed Web of Science ®Google Scholar
• Kamarudin NHN, Jalil AA, Triwahyono S, et al. (2013). Role of 3-aminopropyltriethoxysilane in the preparation of mesoporous silica nanoparticles for ibuprofen delivery: effect on physicochemical properties. Micropor Mesopor Mat 180:235–41.
   Web of Science ®Google Scholar
• Kar M, Tiwari N, Tiwari M, et al. (2013). Poly-L-arginine grafted silica mesoporous nanoparticles for enhanced cellular uptake and their application in DNA delivery and controlled drug release. Part Part Syst Charact 30:166–79.
   Web of Science ®Google Scholar
• Kennedy S, Hu J, Kearney C, et al. (2016). Sequential release of nanoparticle payloads from ultrasonically burstable capsules. Biomaterials 75:91–101.
   PubMed Web of Science ®Google Scholar
• Khung YL, Narducci D. (2015). Surface modification strategies on mesoporous silica nanoparticles for anti-biofouling zwitterionic film grafting. Adv Colloid Interface Sci 226:166–86.
   PubMed Web of Science ®Google Scholar
• Kim Y-H, Lee JK, Kim B, et al. (2013). Combination therapy of cilengitide with belotecan against experimental glioblastoma. Int J Cancer 133:749–56.
   PubMed Web of Science ®Google Scholar
• Lee C-H, Cheng SH, Huang IP, et al. (2010). Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angew Chem Int Ed Engl 49: 8214–9.
   PubMed Web of Science ®Google Scholar
• Lee JE, Lee DJ, Lee N, et al. (2011). Multifunctional mesoporous silica nanocomposite nanoparticles for pH controlled drug release and dual modal imaging. J Mater Chem 21:16869.
   Web of Science ®Google Scholar
• Li Z, Barnes JC, Bosoy A, et al. (2012). Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev 41:2590–605.
   PubMed Web of Science ®Google Scholar
• Li Z, Li H, Liu L, et al. (2015a). A pH-sensitive nanocarrier for co-delivery of doxorubicin and camptothecin to enhance chemotherapeutic efficacy and overcome multidrug resistance in vitro. RSC Adv 5:77097–105.
   Web of Science ®Google Scholar
• Li ZY, Liu Y, Wang XQ, et al. (2013). One-pot construction of functional mesoporous silica nanoparticles for the tumor-acidity-activated synergistic chemotherapy of glioblastoma. ACS Appl Mater Interfaces 5:7995–8001.
   PubMed Web of Science ®Google Scholar
• Li QL, Sun Y, Sun YL, et al. (2014). Mesoporous silica nanoparticles coated by layer-by-layer self-assembly using cucurbit[7]uril for in vitro and in vivo anticancer drug release. Chem Mater 26:6418–31.
   PubMed Web of Science ®Google Scholar
• Li Q-L, Xu S-H, Zhou H, et al. (2015b). pH and glutathione dual-responsive dynamic cross-linked supramolecular network on mesoporous silica nanoparticles for controlled anticancer drug release. ACS Appl Mater Interfaces 7:28656–64.
   PubMed Web of Science ®Google Scholar
• Lu J, Liong M, Zink JI, Tamanoi F. (2007). Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3:1341–6.
   PubMed Web of Science ®Google Scholar
• Luo G-F, Chen W-H, Liu Y, et al. (2013). Charge-reversal plug gate nanovalves on peptide-functionalized mesoporous silica nanoparticles for targeted drug delivery. J Mater Chem B 1:5723.
   PubMed Web of Science ®Google Scholar
• Luo GF, Chen WH, Liu Y, et al. (2014). Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide. Sci Rep 4:6064.
   PubMed Web of Science ®Google Scholar
• Mai WX, Meng H. (2013). Mesoporous silica nanoparticles: a multifunctional nano therapeutic system. Integr Biol 5:19–28.
   Google Scholar
• Mamaeva V, Sahlgren C, Linden M. (2013). Mesoporous silica nanoparticles in medicine – recent advances. Adv Drug Deliv Rev 65:689–702.
   PubMed Web of Science ®Google Scholar
• Martínez-Carmona M, Colilla M, Vallet-Regí M. (2015). Smart mesoporous nanomaterials for antitumor therapy. Nanomaterials 5:1906.
   Web of Science ®Google Scholar
• Miles D, von Minckwitz G, Seidman AD. (2002). Combination versus sequential single-agent therapy in metastatic breast cancer. Oncologist 7(suppl 6):13–9.
   PubMed Web of Science ®Google Scholar
• Mondragon L, Mas N, Ferragud V, et al. (2014). Enzyme-responsive intracellular-controlled release using silica mesoporous nanoparticles capped with ε-poly-L-lysine. Chem Eur J 20:5271–81.
   PubMed Web of Science ®Google Scholar
• Muhammad F, Guo M, Wang A, et al. (2014). Responsive delivery of drug cocktail via mesoporous silica nanolamps. J Colloid Interface Sci 434:1–8.
   PubMed Web of Science ®Google Scholar
• Natarajan SK, Selvaraj S. (2014). Mesoporous silica nanoparticles: importance of surface modifications and its role in drug delivery. RSC Adv 4:14328.
   Web of Science ®Google Scholar
• Nonnenmacher L, Westhoff M-A, Fulda S, et al. (2015). RIST: a potent new combination therapy for glioblastoma. Int J Cancer 136:E173–E187.
   PubMed Web of Science ®Google Scholar
• Park S, Hayes BL, Marankan F, et al. (2003). Regioselective covalent modification of hemoglobin in search of antisickling agents. J Med Chem 46:936–53.
   PubMed Web of Science ®Google Scholar
• Pavillard V, Kherfellah D, Richard S, et al. (2001). Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants. Br J Cancer 85:1077–83.
   PubMed Web of Science ®Google Scholar
• Rosenholm JM, Mamaeva V, Sahlgren C, Lindén M. (2011). Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage. Nanomedicine (Lond) 7:111–20.
   Web of Science ®Google Scholar
• Rosenholm J, Sahlgren C, Linden M. (2010). Cancer-cell targeting and cell-specific delivery by mesoporous silica nanoparticles. J Mater Chem 20:2707–13.
   Web of Science ®Google Scholar
• Schmid B, Chung D-E, Warnecke A, et al. (2007). Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy. Bioconjugate Chem 18:702–16.
   PubMed Web of Science ®Google Scholar
• Shah MA, Schwartz GK. (2000). The relevance of drug sequence in combination chemotherapy. Drug Resist Updat 3:335–56.
   PubMed Web of Science ®Google Scholar
• Shen Y, Jin E, Zhang B, et al. (2010). Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J Am Chem Soc 132:4259–65.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. (2015). Cancer statistics, 2015. CA Cancer J Clin 65:5–29.
   PubMed Web of Science ®Google Scholar
• Slowing II, Vivero-Escoto JL, Trewyn BG, Lin VSY. (2010). Mesoporous silica nanoparticles: structural design and applications. J Mater Chem 20:7924.
   Web of Science ®Google Scholar
• Song N, Yang Y-W. (2015). Molecular and supramolecular switches on mesoporous silica nanoparticles. Chem Soc Rev 44:3474–504.
   PubMed Web of Science ®Google Scholar
• Tian Z, Xu Y, Zhu Y. (2017). Aldehyde-functionalized dendritic mesoporous silica nanoparticles as potential nanocarriers for pH-responsive protein drug delivery. Mater Sci Eng C Mater Biol Appl 71:452–9.
   PubMed Web of Science ®Google Scholar
• Trewyn BG, Slowing II, Giri S, et al. (2007). Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Acc Chem Res 40:846–53.
   PubMed Web of Science ®Google Scholar
• Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS. (2010). Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 6:1952–67.
   PubMed Web of Science ®Google Scholar
• Wang AZ, Langer R, Farokhzad OC. (2012). Nanoparticle delivery of cancer drugs. Annu Rev Med 63:185–98.
   PubMed Web of Science ®Google Scholar
• Wang G, Otuonye AN, Blair EA, et al. (2009). Functionalized mesoporous materials for adsorption and release of different drug molecules: a comparative study. J. Solid State Chem 182:1649–60.
   Web of Science ®Google Scholar
• Wang S, Wang H, Liu Z, et al. (2014a). Smart pH- and reduction-dual-responsive folate-PEG-coated polymeric lipid vesicles for tumor-triggered targeted drug delivery. Nanoscale 6:7635–42.
   PubMed Web of Science ®Google Scholar
• Wang W, Wen Y, Xu L, et al. (2014b). A selective release system based on dual-drug-loaded mesoporous silica for nanoparticle-assisted combination therapy. Chem Eur J 20:7796–802.
   PubMed Web of Science ®Google Scholar
• Wittmann V, Takayama S, Gong KW, et al. (1998). Ligand recognition by E- and P-selectin: chemoenzymatic synthesis and inhibitory activity of bivalent Sialyl Lewis x derivatives and Sialyl Lewis x carboxylic acids. J Org Chem 63:5137–43.
   Web of Science ®Google Scholar
• Xu Z, Liu S, Kang Y, Wang M. (2015a). Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy. Nanoscale 7:5859–68.
   PubMed Web of Science ®Google Scholar
• Xu W, Thapa R, Liu D, Nissinen T, Granroth S, Narvanen A, Suvanto M, Santos HA, Lehto VP. (2015b). Smart porous silicon nanoparticles with polymeric coatings for sequential combination therapy. Mol Pharmaceutics 12:4038–47.
   PubMed Web of Science ®Google Scholar
• Yang KN, Zhang CQ, Wang W, et al. (2014). pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment. Cancer Biol. Med 11:34–43.
   PubMedGoogle Scholar
• Zhang Y-C, Zhang D-W, Wang H, et al. (2015). Bipyridinium radical cation dimerization-driven polymeric pleated foldamers and a homoduplex that undergo ion-tuned interconversion. Polym Chem 6:4404–8.
   Web of Science ®Google Scholar
• Zhao Y, Trewyn BG, Slowing II, Lin VS. (2009). Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP. J Am Chem Soc 131:8398–400.
   PubMed Web of Science ®Google Scholar
• Zhou S, Sha H, Ke X, et al. (2015). Combination drug release of smart cyclodextrin-gated mesoporous silica nanovehicles. Chem Commun 51:7203–6.
   PubMed Web of Science ®Google Scholar